Perpetuation of Premium for New Drug Development Will Depend on Convincing Data: HIB Director General Kikura

Yoshiyuki Kikura, Director General, Health Insurance Bureau Yoshiyuki Kikura, who assumed office as director general of the Health Insurance Bureau (HIB) on September 10, told reporters from industry journals on September 28 that the full introduction and perpetuation of the...read more